Background: Cleft lip/palate (CLP) affects 1 in 500-700 live births and is the most common human craniofacial defect. Pbx homeoproteins have been linked to normal craniofacial development through activation of the transcriptional regulators Wnt9-Wnt3, which control apoptotic programs in the embryonic lambdoidal junction of the developing midface. Previous work has demonstrated that compound loss of Pbx results in fully penetrant CLP by disruption of Wnt9b-Wnt3 transcriptional regulation. We sought to restore normal facial morphogenesis in compound Pbx-deficient mice via genetic engineering and subsequent reactivation of genetic programs that control apoptosis.
